Retatrutide is a next-generation investigational peptide being studied for its potential effects on metabolic regulation and weight management. It is a triple-agonist peptide designed to target three key hormone receptors involved in energy balance and metabolism: GLP-1, GIP, and glucagon receptors. By acting on these pathways simultaneously, Retatrutide is being researched for its ability to influence appetite regulation, energy expenditure, and glucose metabolism.
Early research has shown promising results in areas such as body weight reduction, metabolic health, and improved insulin sensitivity, making it a subject of significant interest within the metabolic and obesity research field.
This compound is typically supplied in lyophilized (freeze-dried) form and is intended strictly for laboratory research purposes only. It is not approved for human or veterinary use outside of controlled clinical research.
Key Features
• Triple hormone receptor agonist (GLP-1, GIP, Glucagon)
• High purity research peptide
• Lyophilized powder for stability
• Designed for metabolic and obesity research studies
• For research use only
Reviews
There are no reviews yet.